The Role of Herpes Simplex Virus Type 2 and Other Genital Infections in the Acquisition of HIV‐1 among High‐Risk Women in Northern Tanzania
Departments of 1Population and International Health, 2Epidemiology, and 3Immunology and Infections Diseases, Harvard School of Public Health, Boston, Massachusetts; 4Division of Biostatistics and Epidemiology, Department of Public Health, Weill Medical College of Cornell University, New York, New York; 5International Partnership for Microbicides, Silver Spring, Maryland; 6Kilimanjaro Reproductive Health Program and 7Department of Clinical Laboratories, Kilimanjaro Christian Medical Centre, Moshi, Tanzania
Background.
We examined the role of herpes simplex virus type 2 (HSV‐2) and other genital infections on human immunodeficiency virus type 1 (HIV‐1) incidence in a cohort study conducted between 2002 and 2005 among female bar/hotel workers in Moshi, Tanzania.
Methods.
At baseline and every 3 months thereafter, participants were interviewed, and blood and genital samples were collected. Predictors of HIV‐1 incidence were evaluated using a Cox proportional hazards regression model.
Results.
Of 845 women who were HIV‐1 seronegative at baseline, 689 (81.5%) were monitored in the study for a total of 698.6 person‐years at risk (PYARs). The overall HIV‐1 incidence was 4.6/100 PYARs (95% confidence interval [CI], 3.0–6.2/100 PYARs), and condom use was very low. After adjustment for other risk factors, the risk of HIV‐1 was increased among women with HSV‐2 at baseline (hazard ratio [HR], 4.3 [95% CI, 1.5–12.4]) and in those who acquired HSV‐2 during the study period (HR, 5.5 [95% CI, 1.2–25.4]). Other independent predictors of HIV‐1 were baseline chlamydial infection (HR, 5.2), bacterial vaginosis (HR, 2.1), and the occurrence of genital ulcers (HR, 2.7).
Conclusion.
HSV‐2 and other genital infections were the most important risk factors for HIV‐1. Control of these infections could help to reduce HIV‐1 incidence in this population.
Received 5 June 2006; accepted 10 November 2006; electronically published 15 March 2007.
-
(See the editorial commentary by Corey, on pages 1242–4, and the article by Cachay et al., on pages 1270–7.)
Cited by
Online publication date: 1-Aug-2009.
CrossRef
Online publication date: 16-May-2009.
CrossRef
Online publication date: 1-Apr-2009.
Online publication date: 1-Apr-2009.
CrossRef
Online publication date: 1-Mar-2009.
CrossRef
Online publication date: 1-Feb-2009.
CrossRef
Online publication date: 1-Jan-2009.
CrossRef
Online publication date: 1-Jul-2008.
CrossRef
Online publication date: 1-Mar-2008.
CrossRef
Online publication date: 1-Jan-2008.
CrossRef
Online publication date: 1-May-2007.
-
Potential conflicts of interest: none reported.
Financial support: Rockefeller Foundation (grant 2002 HE 036); International Partnership for Microbicides.





